ticlopidine has been researched along with Experimental Mammary Neoplasms in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Su, X | 1 |
Floyd, DH | 1 |
Hughes, A | 1 |
Xiang, J | 1 |
Schneider, JG | 1 |
Uluckan, O | 1 |
Heller, E | 1 |
Deng, H | 1 |
Zou, W | 1 |
Craft, CS | 1 |
Wu, K | 1 |
Hirbe, AC | 1 |
Grabowska, D | 1 |
Eagleton, MC | 1 |
Townsley, S | 1 |
Collins, L | 1 |
Piwnica-Worms, D | 1 |
Steinberg, TH | 1 |
Novack, DV | 1 |
Conley, PB | 1 |
Hurchla, MA | 1 |
Rogers, M | 1 |
Weilbaecher, KN | 1 |
1 other study available for ticlopidine and Experimental Mammary Neoplasms
Article | Year |
---|---|
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.
Topics: Adenosine Diphosphate; Animals; Arthritis, Experimental; Bone Neoplasms; Bone Remodeling; Bone Resor | 2012 |